Distribution of murine adipose-derived mesenchymal stem cells in vivo following transplantation in developing mice

Stem Cells and Development

Volumn 17, Issue 2, 2008, Pages 303-314

  Liao, Xinbo ^a   Li, Feng ^a   Wang, Xujung ^a   Yanoso, Jacquelyn ^a   Niyibizi, Christopher ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA1;

ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE TISSUE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MIGRATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENGRAFTMENT; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADIPOGENESIS; ADIPOSE TISSUE; AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL MARKERS; BONE AND BONES; BONE MARROW CELLS; CELL MOVEMENT; GREEN FLUORESCENT PROTEINS; GROWTH AND DEVELOPMENT; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED C57BL; OSTEOGENESIS;

MURINAE; MUS;

EID: 43049105415     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2007.0086     Document Type: Article

References (40)

1. Bianco P, M Riminucci, S Gronthos and PG Robey. (2001). Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19:180-192.
2. Yoon YS, A Wecker, L Heyd , JS Park, T Tkebuchava , K Kusano , A Hanley, H Scadova , G Qin , DH Cha , KL Johnson, R Aikawa , T Asahara and DW Losordo. (2005). Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. J Clin Invest 15:326-338.
3. Peterson B, J Zhang, R Iglesias , M Kabo, M Hedrick, P Benhaim, JR Lieberman. (2005). Healing of critically sized femoral defects, using genetically modified mesenchymal stem cells from human adipose tissue. Tissue Eng 11:120-129.
4. Robey PG and P Bianco. (2006). The use of adult stem cells in rebuilding the human face. J Am Dent Assoc 137:961-972.
5. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal , R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
6. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, H Mizuno, ZC Alfonso, JK Fraser, P Benhaim and MH Hedrick. (2002). Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 3:4279-4295.
7. Lendeckel S, A Jodicke, P Christophis, K Heidinger, J Wolff and JK Fraser. (2004). Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report. J Craniomaxillofac Surg 32:370-373.
8. Gronthos S, AC Zannettino, SJ Hay, S Shi, SE Graves, A Kortesidis, SE Graves SE and PJ Simmons. (2003). Molecular and cellular characterization of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 116:1827-1835.
9. Caplan AI. (1991). Mesenchymal stem cells. J Orthop Res 9:641-650.
10. Herzog EL, L Chai and DS Krause. Plasticity of marrow-derived stem cells. (2003). Blood 102:3483-3493.
11. Prockop DJ. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1276:71-74.
12. Huang JI, N Kazmi , MM Durbhakula, TM Hering , JU Yoo and B Johnstone. (2005). Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: a patient-matched comparison. J Orthop Res 23:1383-1389.
13. Niyibizi C, SJ Wang, Z Mi and PD Robbins. (2004). The fate of mesenchymal stem cells transplanted into immunocompetent neonatal mice: implications for skeletal gene therapy via stem cells. Mol Ther 9:955-963.
14. Wang X, F Li and C Niyibizi. (2006). Progenitors systemically transplanted into neonatal mice localize to areas of active bone formation in vivo: implications of cell therapy for skeletal diseases. Stem Cells 24:1869-1878.
15. Pereira RF, KW Halford, MD O'Hara, DB Leeper, BP Sokolov, MD Pollard, O Bagasra and DJ Prockop. (1995). Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Natl Acad Sci USA 92:4857-4861.
16. Li F, Wang X, Niyibizi C. (2007). Distribution of single-cell expanded marrow derived progenitors in a developing mouse model of osteogenesis imperfecta following systemic transplantation. Stem Cells 25:3183-3193.
17. Devine SM, C Cobbs, M Jennings, A Bartholomew, R Hoffman. (2003). Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 101:2999-3001.
18. Devine SM, AM Bartholomew, N Mahmud, M Nelson, S Patil, W Hardy, C Sturgeon, T Hewett, T Chung, W Stock, D Sher, S Weissman, K Ferrer, J Mosca, R Deans, A Moseley and R Hoffman. (2001). Mesenchymal stem cells are capable of homing to the bone marrow of non-human primates following systemic infusion ExpHematol 29:244-255.
19. Horwitz EM, DJ Prockop, LA Fitzpatrick, WW Koo, PL Gordon, M Neel , M Sussman, P Orchard , JC Marx, RE Pyeritz and MK Brenner. (1999). Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nature Med 5:309-313.
20. Horwitz EM, PL Gordon, WK Koo, JC Marx, MD Neel, RY McNall, L Muul and T Hofmann. (2002). Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 99:8932-8937.
21. Wang L, Y Liu, Z Kalajzic, X Jiang and DW Rowe. (2005) Heterogeneity of engrafted bone-lining cells after systemic and local transplantation. Blood 106:3650-3657.
22. Anjos-Afonso F, EK Siapati and D Bonnet. (2004). In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J Cell Sci 117:5655-5664.
23. Gao J, JE Dennis, RF Muzic, M Lundberg and AI Caplan. (2001). The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 169:12-20.
24. Gambotto A, G. Dworacki, V Cicinnati, T Kenniston, J Steitz, T Tuting, PD Robbins and AB DeLeo. (2000). Immunogenicity of enhanced green fluorescent protein (EGFP) in BALB/c mice: identification of an H2-Kd-restricted CTL epitope. Gene Ther 7:2036-2040.
25. Ogawa R, H Mizuno, A Watanabe, M Migita and T Shimada. (2004). Adipogenic differentiation by adipose-derived stem cells harvested from GFP transgenic mice-including relationship of sex differences. Biochem Biophys Res Commun 319:511-517.
26. Kominsky SL, M Doucet, K Brady and KL Weber. (2007). TGF-Beta promotes the establishment of renal cell carcinoma bone metastasis. J Bone Miner Res 22:37-44.
27. Prime SS, JW Eveson, AM Stone, SP Huntley, M Davies, IC Paterson and CM Robinson. (2004). Metastatic dissemination of human malignant oral keratinocyte cell lines following orthotopic transplantation reflects response to TGF-beta 1. J Pathol 203:927-932.
28. Yin JJ, CB Pollock and K Kelly. Mechanisms of cancer metastasis to the bone. (2005). Cell Res 15:57-62.
29. Roodman GD. (2004). Mechanisms of bone metastasis. N Engl J Med 350:1655-1664.
30. Pratap J, JB Lian, A Javed, GL Barnes, AJ van Wijnen and JL Stein. (2006). Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone. Cancer Metastasis Rev 25:589-600.
31. Barnes GL, KE Hebert, M Kamal, A Javed, TA Einhorn, JB Lian, GS Stein and LC Gerstenfeld. (2004). Fidelity of Runx2 activity in breast cancer cells is required for the generation of metastases-associated osteolytic disease. Cancer Res. 64:4506-4513.
32. Kobayashi T and H Kronenberg. (2005) Minireview: transcriptional regulation in development of Bone. Endocrinology 146:1012-1017.
33. Kim YJ, HN Kim, EK Park, BH Lee, HM Ryoo and SY Kim. (2006). The bone-related Zn finger transcription factor Osterix promotes proliferation of mesenchymal cells. Gene 366:145-151
34. Mackenzie TC and AW Flake. (2001). Human mesenchymal stem cells persist, demonstrate site-specific multipotential differentiation, and are present in sites of wound healing and tissue regeneration after transplantation into fetal sheep. Blood Cells Mol Dis 27:601-604.
35. Komori T, H Yagi, S Nomura , A Yamaguchi , K Sasaki, K Deguchi, Y Shimizu, RT Bronson, Y HGao, M Inada, M Sato, R Okamoto, Y Kitamura, S Yoshiki and T Kishimoto. (1997). Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
36. Janssens K, ten Dijke P, S Janssens and W Van Hul. (2005). Transforming growth factor-beta1 to the bone. Endocr Rev 26:743-774.
37. Ducy P, R Zhang, V Geoffroy, AL Ridall and G Karsenty. (1997) Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89:747-754.
38. Nakashima K, X Zhou, G Kunkel, Z Zhang, JM Deng, RR Behringer and B de Crombrugghe. (2002). The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108: 17-29.
39. Alvarez-Dolado M, R Pardal R, JM Garcia-Verdugo, JR Fike, HO Lee, K Pfeffer, C Lois, JA Morrison and A Alvarez-Buylla. (2003). Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425:968-973.
40. Komori T. (2006). Regulation of osteoblast differentiation by transcription factors. J Cell Biochem 99:1233-1239.